Calgary, Alberta. November 4, 2025 -- SuperQ Quantum Computing Inc. QBTQ ("SuperQ Quantum", "SuperQ", or the "Company"),  has entered into a commercial agreement with Science & Humans  ("S&H"), a Canadian hormonal health company and a recipient of the Deloitte Technology Fast 50 recognition in 2025, to deploy quantum-AI powered clinician solutions  for S&H. Under the agreement, SuperQ will architect and deliver AI  clinicians enhanced by quantum computing based optimization for S&H  to integrate into its real-world healthcare workflows.

Addressing Challenges of Increased Clinical Demands

S&H  is an Ontario-based provider of hormonal healthcare including  menopause, thyroid conditions, sexual health and more. It has been  experiencing significant user growth and is one of the Deloitte's  Technology Fast 50 companies this year. S&H requires autonomous  systems such as diagnostic and treatment AI to keep up with the  increased demand. High accuracy and speed are key considerations for  this sensitive life sciences use case. S&H's scientific and clinical  teams are providing the domain expertise and knowledge base for these  systems.

SuperQ is building these systems  for S&H through its professional services and Super platform, which  enables development of quantum-AI products. Super implements  interoperability across quantum hardware types (annealing, gate-based,  hybrid classical/quantum) and integrates high-performance classical  compute, AI-driven orchestration and quantum processing. This "gateway"  approach enables enterprises and healthcare institutions to leverage  emerging quantum architectures along with GPU-based AI pipelines without  being locked into a single hardware ecosystem.

Aftab  Pashaw, CEO of S&H, commented: "We are excited to be the first to  explore frontier AI and quantum technologies in clinical diagnosis and  treatment. SuperQ is playing a key role in the development, integration  and enhancement of our clinical AI systems. Together, we have already  reached the MVP stage and aim to reach full production in the coming  months."

Strategic Implications in the Backdrop of NVIDIA Announcements

The  recent unveiling of NVIDIA's NVQLink interconnect at NVIDIA GTC DC  marks a pivotal shift in how quantum and classical compute  infrastructure will collaborate, a shift that directly amplifies the  strategic value of SuperQ's Super platform. NVIDIA is now doing at the  hardware level what SuperQ has been doing at the software level -  interlacing classical and quantum computing to create real-world value.

The "Quantum,  AI and High-performance Computing: intersection Opportunities" meetup  organized by Dr. Khan at the NVIDIA GTC explored this coupling in  detail. The participants agreed that we have entered a hybrid  classical-quantum reality. NVIDIA's hardware announcements reinforce  SuperQ's vision of driving commercial value from hybrid compute. Super  gateway platform is purpose-built to orchestrate classical compute, AI  pipelines and multiple quantum hardware types (annealing, gate-based,  hybrid), especially in sensitive industries like healthcare where  reliability, interpretability and speed are non-negotiable.

"Commercial  use cases for the Super platform and related professional services are  growing by the day," said Dr. Muhammad Khan, CEO & Board Chair of  SuperQ. "The Science & Humans project signals that quantum-AI is now  ready to transform clinician workflows, where the margin for error is  minimal and the stakes are highest."

Project Highlights

SuperQ will architect and deliver quantum-AI clinician systems in domains  where accuracy, interpretability and reliability are paramount -  including patient triage, autonomous monitoring, treatment optimisation  and decision-support in sensitive care environments.

The initial roadmap entails a phased-deployment approach:

• Triaging patients and enhancing diagnostic decision-support.
• Streamlining prescription workflows.
• Extending into chronic disease management, real-time patient monitoring and broader healthcare-system logistics.

This agreement  complements SuperQ's recent hardware-and‐software roadmap expansion,  including the launch of its Super hybrid quantum-classical platform and  the initiation of quantum-hardware development - positioning SuperQ as one of the few, if not the first, bridging quantum-AI architecture with  commercial-healthcare solutions.